FluoroPharma Medical, Inc. (OTCBB:FPMI) announced a private placement of 1,819,118 common shares and warrants at $0.85 per share for gross proceeds of $1,546,250 on November 19, 2012. The warrants will be exercisable at $0.90 per share till one year from the closing. The securities are issued to 14 accredited investors pursuant to Regulation D. The company planned to receive minimum gross proceeds of $1,500,000 and a maximum of gross proceeds of $4,000,000. The company may sell securities up to an additional $1,000,000. Brookline Group, LLC served as placement agent to the company and received a cash fee of $123,700 and five-year warrants to purchase 181,912 shares of common stock at an exercise price of $0.85 per share. David J. Levine from Loeb & Loeb LLP served as legal advisor to the company.

On November 19, 2012, FluoroPharma Medical, Inc closed the transaction.